Mesoblast's average one-year price target was raised to $26.06 per share from $15.33, a 69.97% increase. The revision is a positive analyst signal, though the article only reports a consensus target update rather than new operating results or company-specific catalysts. The news is likely supportive for sentiment but modest in immediate market impact.
Mesoblast's average one-year price target was raised to $26.06 per share from $15.33, a 69.97% increase. The revision is a positive analyst signal, though the article only reports a consensus target update rather than new operating results or company-specific catalysts. The news is likely supportive for sentiment but modest in immediate market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
